Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Lung Neoplasms D008175 171 associated lipids
Adenocarcinoma D000230 166 associated lipids
Edema D004487 152 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hemolysis D006461 131 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Inflammation D007249 119 associated lipids
Insulin Resistance D007333 99 associated lipids
Brain Ischemia D002545 89 associated lipids
Atherosclerosis D050197 85 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Hyperlipidemias D006949 73 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Parkinson Disease D010300 53 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Precancerous Conditions D011230 48 associated lipids
Leukemia P388 D007941 43 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
De Saint-Hubert M et al. Molecular imaging of cell death. 2009 Methods pmid:19362149
Kim YH et al. Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study. 2009 Acta Haematol. pmid:19332985
Muñoz M et al. Intravenous iron in inflammatory bowel disease. 2009 World J. Gastroenterol. pmid:19787830
Vanin S et al. Seasonal variation of trehalose and glycerol concentrations in winter snow-active insects. 2008 Nov-Dec Cryo Letters pmid:19280052
Usmanov RI et al. Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. 2008 Mar-Apr J. Nephrol. pmid:18446719
Li H and Wang SX Intravenous iron sucrose in peritoneal dialysis patients with renal anemia. 2008 Mar-Apr Perit Dial Int pmid:18332450
Nakamura Y et al. Decreased valproate level caused by VPA-glucuronidase inhibition by carbapenem antibiotics. 2008 Drug Metab Lett pmid:19356106
Picker SM et al. Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units. 2008 Transfusion pmid:18513255
Kuo KL et al. Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients. 2008 J. Am. Soc. Nephrol. pmid:18495964
Auerbach M and Ballard H Intravenous iron in oncology. 2008 J Natl Compr Canc Netw pmid:18597712
Pinsk V et al. Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia. 2008 Isr. Med. Assoc. J. pmid:18605353
Kaplinsky C Parenteral iron therapy. 2008 Isr. Med. Assoc. J. pmid:18605363
Cuenca J et al. Efficacy of intravenous iron sucrose administration for correcting preoperative anemia in patients scheduled for major orthopedic surgery. 2008 Anesthesiology pmid:18580186
Zółtaszek R et al. [The biological role of D-glucaric acid and its derivatives: potential use in medicine]. 2008 Postepy Hig Med Dosw (Online) pmid:18772850
Stefánsson BV et al. Ascorbyl free radical reflects catalytically active iron after intravenous iron saccharate injection. 2008 Free Radic. Biol. Med. pmid:18775775
Oleson L and Court MH Effect of the beta-glucuronidase inhibitor saccharolactone on glucuronidation by human tissue microsomes and recombinant UDP-glucuronosyltransferases. 2008 J. Pharm. Pharmacol. pmid:18718121
Aghaie A et al. New insights into the alternative D-glucarate degradation pathway. 2008 J. Biol. Chem. pmid:18364348
Al-Saran KA and Sabry AA Pregnancy in dialysis patients: a case series. 2008 J Med Case Rep pmid:18205953
Bolaños L et al. Intravenous iron sucrose does not impair sonographic brachial vasodilation in peritoneal dialysis patients. 2008 Adv Perit Dial pmid:18986009
Gonçalves P et al. The effect of high glucose on SERT, the human plasmalemmal serotonin transporter. 2008 Nutr Neurosci pmid:19000377
Anirban G et al. The comparative safety of various intravenous iron preparations in chronic kidney disease patients. 2008 Ren Fail pmid:18661414
Wang S et al. Chemical reactions of vitamin C with intravenous-iron formulations. 2008 Nephrol. Dial. Transplant. pmid:17951305
Saluk-Juszczak J et al. Protective effects of D-glucaro-1,4-lactone against oxidative modifications in blood platelets. 2008 Nutr Metab Cardiovasc Dis pmid:17933501
Teschke O et al. Quorum sensing detected by atomic force microscopy imaging of corrals surrounding multicellular arrangement of bacteria. 2008 Microsc. Res. Tech. pmid:17943987
Roth S et al. Comparative toxicity and cell-tissue distribution study on nanoparticular iron complexes using avian embryos and HepG2-cells. 2008 Transl Res pmid:18061126
Liu Z et al. Evaluating the protective role of ischaemic preconditioning in rat hearts using a stationary small-animal SPECT imager and 99mTc-glucarate. 2008 Nucl Med Commun pmid:18094633
Wall GC and Pauly RA Evaluation of total-dose iron sucrose infusions in patients with iron deficiency anemia. 2008 Am J Health Syst Pharm pmid:18192261
Li H and Wang SX Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia. 2008 Blood Purif. pmid:18212498
Hasegawa K et al. [Improvement of urinary d-glucaric acid assay and its application]. 2008 Yakugaku Zasshi pmid:18176065
Jaber BL Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease. 2008 Kidney Int. pmid:18235527
Olas B et al. D-glucaro 1,4-lactone and resveratrol as antioxidants in blood platelets. 2008 Cell Biol. Toxicol. pmid:17846905
Perek N et al. Could 99mTc-glucarate be used to evaluate tumour necrosis? In vitro and in vivo studies in leukaemic tumour cell line U937. 2008 Eur. J. Nucl. Med. Mol. Imaging pmid:18338166
Lim R et al. A permanent tan from iron. 2008 Kidney Int. pmid:18340355
Auerbach M et al. The role of intravenous iron in anemia management and transfusion avoidance. 2008 Transfusion pmid:18346021
Auerbach M and Al Talib K Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease. 2008 Kidney Int. pmid:18274543
Lord RS and Bralley JA Clinical applications of urinary organic acids. Part I: Detoxification markers. 2008 Altern Med Rev pmid:18950247
Kim YT et al. Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy. 2007 Gynecol. Oncol. pmid:17234260
Olas B et al. Protective effects of D-glucaro 1,4-lactone against oxidative/nitrative modifications of plasma proteins. 2007 Nutrition pmid:17234507
Yew WS et al. Evolution of enzymatic activities in the enolase superfamily: L-talarate/galactarate dehydratase from Salmonella typhimurium LT2. 2007 Biochemistry pmid:17649980
Sato K [Drug-induced osteomalacia]. 2007 Clin Calcium pmid:17906405
Toblli JE et al. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. 2007 J. Am. Coll. Cardiol. pmid:17950147
Francis GS and Kanderian A Anemia and heart failure a new pathway? 2007 J. Am. Coll. Cardiol. pmid:17950148
Beck-da-Silva L et al. Rationale and design of the IRON-HF study: a randomized trial to assess the effects of iron supplementation in heart failure patients with anemia. 2007 J. Card. Fail. pmid:17338998
Sane R et al. Safe administration of iron sucrose in a patient with a previous hypersensitivity reaction to ferric gluconate. 2007 Pharmacotherapy pmid:17381390
Breymann C et al. Milk iron content in breast-feeding mothers after administration of intravenous iron sucrose complex. 2007 J Perinat Med pmid:17302514
Breborowicz A et al. Peritoneal effects of intravenous iron sucrose administration in rats. 2007 Transl Res pmid:17543848
Grzegorzewska AE [Administration of iron-containing drugs in non-dialyzed patients with chronic kidney disease]. 2007 Pol. Arch. Med. Wewn. pmid:17722476
Singh J and Gupta KP Induction of apoptosis by calcium D-glucarate in 7,12-dimethyl benz [a] anthracene-exposed mouse skin. 2007 J. Environ. Pathol. Toxicol. Oncol. pmid:17725531
Thomas J and Martinez A Blood conservation in the critically ill. 2007 Am J Health Syst Pharm pmid:17687066
Malindretos P et al. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran. 2007 Am. J. Nephrol. pmid:17804904